Table 2.

Primary and Secondary Outcomes.

Outcome	Ketorolac (n = 89)	Control Arm (n = 89)	p-Value
Hospital mortality, n (%)	2 (2.2)	3 (3.3)	0.605
All cause 30-day mortality, n (%)	2 (2.2)	3 (3.3)	0.605
MI, n (%)	0 (0)	0 (0)	--
Clinically significant bleeding, n (%)	5 (5.6)	6 (6.7)	0.58
Decrease in hemoglobin, mean ± SD	4.6 ± 1.5	4.6 ± 1.8	0.61
Decrease in platelets, median (IQR)	74 (11–121)	72 (19–153)	0.17

n: number, MI: myocardial infarction, SD: standard deviation, IQR: interquartile range.